cyclosporine has been researched along with Cognitive Dysfunction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dai, Z; Herz, J; Huuskonen, MT; Kisler, K; Körbelin, J; Ma, Q; Montagne, A; Nikolakopoulou, AM; Rege, SV; Sagare, AP; Wang, Y; Zhao, Z; Zlokovic, BV | 1 |
Barg-Hock, H; Beneke, J; Ding, X; Jäckel, E; Klempnauer, J; Lanfermann, H; Pflugrad, H; Schrader, AK; Schrem, H; Tryc, AB; Weissenborn, K | 1 |
Elia, M; Huang, J | 1 |
3 other study(ies) available for cyclosporine and Cognitive Dysfunction
Article | Year |
---|---|
Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Cells, Cultured; Cognitive Dysfunction; Cyclophilin A; Cyclosporine; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Female; Gene Knockout Techniques; Genetic Therapy; Low Density Lipoprotein Receptor-Related Protein-1; Male; Matrix Metalloproteinase 9; Mice; Mice, Transgenic; Neurons; Signal Transduction | 2021 |
Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation.
Topics: Aged; Brain; Calcineurin Inhibitors; Cognitive Dysfunction; Cyclosporine; End Stage Liver Disease; Female; Graft Rejection; Humans; Immunosuppression Therapy; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Tacrolimus; Time Factors | 2018 |
Decreased Vision and Cognitive Decline.
Topics: Adult; Antibiotics, Antineoplastic; Cognitive Dysfunction; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Mycophenolic Acid; Retinal Vasculitis; Vision, Low; Visual Acuity | 2016 |